GSK Spends Heavily On iTeos' TIGIT To Build A New IO Cornerstone

Fist Bump
GSK has teamed up with iTeos on a TIGIT antibody • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category